Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dyslipidemia

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    February 2017
  1. KHERA AV, Kathiresan S
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498-9.
    PubMed     Text format    


  2. MARTIN AC, Watts GF
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498.
    PubMed     Text format    


  3. KULLO IJ, Safarova MS
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498.
    PubMed     Text format    


  4. HINGORANI AD, Futema M, Humphries S
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:499.
    PubMed     Text format    



  5. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498-500.
    PubMed     Text format    


    January 2017
  6. SCHULMAN AR, Vaidya A, Tavakkoli A, Jajoo K, et al
    Making the Connection.
    N Engl J Med. 2017;376:e5.
    PubMed     Text format    


    October 2016
  7. WALD DS, Bestwick JP, Morris JK, Whyte K, et al
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2016;375:1628-1637.
    PubMed     Text format     Abstract available


  8. MCCRINDLE BW, Gidding SS
    What Should Be the Screening Strategy for Familial Hypercholesterolemia?
    N Engl J Med. 2016;375:1685-1686.
    PubMed     Text format    


    September 2016
  9. LAMPSON BL, Gray SW, Cibas ES, Levy BD, et al
    CLINICAL PROBLEM-SOLVING. Tip of the Tongue.
    N Engl J Med. 2016;375:880-6.
    PubMed     Text format    


    May 2016
  10. CUSHMAN WC, Goff DC Jr
    More HOPE for Prevention with Statins.
    N Engl J Med. 2016;374:2085-7.
    PubMed     Text format    


    April 2016
  11. YUSUF S, Bosch J, Dagenais G, Zhu J, et al
    Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    March 2016
  12. KERSTEN S
    The Genetics of Dyslipidemia--When Less Is More.
    N Engl J Med. 2016;374:1192-3.
    PubMed     Text format    


    January 2016
  13. INGE TH, Courcoulas AP, Jenkins TM, Michalsky MP, et al
    Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.
    N Engl J Med. 2016;374:113-23.
    PubMed     Text format     Abstract available


    October 2015
  14. EVERETT BM, Smith RJ, Hiatt WR
    Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs.
    N Engl J Med. 2015;373:1588-91.
    PubMed     Text format    


  15. SCHULMAN KA, Balu S, Reed SD
    Specialty Pharmaceuticals for Hyperlipidemia - Impact on Insurance Premiums.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    September 2015
  16. BURTON BK, Balwani M, Feillet F, Baric I, et al
    A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.
    N Engl J Med. 2015;373:1010-20.
    PubMed     Text format     Abstract available


    August 2015
  17. SABATINE MS, Wasserman SM, Stein EA
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:774-5.
    PubMed     Text format    


  18. GOEMANN IM, Londero TM, Dora JM
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:773-4.
    PubMed     Text format    


  19. AUER J, Berent R, Primus C
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:773.
    PubMed     Text format    


  20. ROBINSON JG, Kastelein JJ
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:774.
    PubMed     Text format    


    July 2015
  21. GAUDET D, Alexander VJ, Baker BF, Brisson D, et al
    Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.
    N Engl J Med. 2015;373:438-47.
    PubMed     Text format     Abstract available


  22. PI-SUNYER X, Astrup A, Fujioka K, Greenway F, et al
    A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
    N Engl J Med. 2015;373:11-22.
    PubMed     Text format     Abstract available


    April 2015
  23. STONE NJ, Lloyd-Jones DM
    Lowering LDL cholesterol is good, but how and in whom?
    N Engl J Med. 2015;372:1564-5.
    PubMed     Text format    


  24. NELSON CP, Hamby SE, Saleheen D, Hopewell JC, et al
    Genetically Determined Height and Coronary Artery Disease.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    March 2015
  25. SABATINE MS, Giugliano RP, Wiviott SD, Raal FJ, et al
    Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  26. ROBINSON JG, Farnier M, Krempf M, Bergeron J, et al
    Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    December 2014
  27. STEFAN N, Schick F, Haring HU
    Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease.
    N Engl J Med. 2014;371:2236-7.
    PubMed     Text format    


  28. ARAGON JJ, Martinez-Costa OH
    Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease.
    N Engl J Med. 2014;371:2236.
    PubMed     Text format    


  29. SHIN SW, Lee SJ
    Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease.
    N Engl J Med. 2014;371:2236.
    PubMed     Text format    


  30. SHULMAN GI
    Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease.
    N Engl J Med. 2014;371:2237-8.
    PubMed     Text format    


  31. GAUDET D, Brisson D, Tremblay K, Alexander VJ, et al
    Targeting APOC3 in the familial chylomicronemia syndrome.
    N Engl J Med. 2014;371:2200-6.
    PubMed     Text format     Abstract available


    November 2014
  32. MAYER L
    Niacin for reduction of cardiovascular risk.
    N Engl J Med. 2014;371:1943.
    PubMed     Text format    


  33. SANTOS-GALLEGO CG, Badimon J
    Niacin for reduction of cardiovascular risk.
    N Engl J Med. 2014;371:1943.
    PubMed     Text format    


  34. VAN DEN OEVER IA, Nurmohamed MT, Lems WF
    Niacin for reduction of cardiovascular risk.
    N Engl J Med. 2014;371:1942.
    PubMed     Text format    


  35. HU M, Tomlinson B
    Niacin for reduction of cardiovascular risk.
    N Engl J Med. 2014;371:1941-2.
    PubMed     Text format    


  36. MENESES F
    Niacin for reduction of cardiovascular risk.
    N Engl J Med. 2014;371:1941.
    PubMed     Text format    


  37. REMBOLD CM
    Niacin for reduction of cardiovascular risk.
    N Engl J Med. 2014;371:1940-1.
    PubMed     Text format    


  38. LANDRAY MJ, Haynes R, Armitage J
    Niacin for reduction of cardiovascular risk.
    N Engl J Med. 2014;371:1943-4.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: